Altrafin Ag originally filed its 13F report for Q2 2026 on July 15, 2026. The filing was subsequently amended, with the latest update submitted on July 20, 2026. The portfolio totaled 255.33 M reflecting a -12.01% change from the prior quarter, spanning 44 assets. The top 10 holdings comprised 62.8% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 4 new positions and 12 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Yes. Altrafin originally filed on 07/15/2026 and subsequently submitted 1 amendment(s). The latest filing (13F-HR/A) was submitted on 07/20/2026.
In the Q2 2026 filing, Altrafin reported a managed portfolio value of 255.33 M, consisting of 44 individual positions.
Multiple filings indicate that Altrafin updated their Q2 2026 report. The initial filing was submitted on 07/15/2026, followed by amendments to correct data or disclose previously confidential holdings.
This page displays the raw filing documents. To see which stocks Altrafin bought or sold during Q2 2026, please visit Altrafin's Portfolio Analysis page.